Study finds link between early coronary heart disease and dementia

Adults diagnosed with coronary heart disease, especially before the age of 45, may be at increased risk of developing dementia, Alzheimer’s disease and vascular dementia later in life, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

Novartis is buying gene therapy and neuroscience biotech Kate Therapeutics in a deal worth $1.1 billion in upfront and milestone payments, the Swiss pharma confirmed

November 22, 2024

Neurocrine’s depression drug passes Phase 2 trial

Neurocrine Biosciences reported that its pill for major depressive disorder reduced scores on a depression severity scale at about one month in a Phase 2

April 24, 2024

BetterLife Pharma to Host Investors Update Call on September 18, 2023 – Psychedelic Alpha

VANCOUVER, British Columbia, Sept. 14, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging

September 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.